Acute pancreatitis linked to bevacizumab: A case report
Introduction: The monoclonal anti-vascular endothelial growth factor antibody bevacizumab is increasingly being used in the treatment of malignant tumors. It is the first molecular-targeted agent used in the treatment of several ovarian cancers. The typical side effects of this drug are hypertension...
Сохранить в:
| Главные авторы: | , , , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Turkish Society of Oncology
2018-08-01
|
| Серии: | Journal of Oncological Sciences |
| Online-ссылка: | http://www.sciencedirect.com/science/article/pii/S245233641730105X |
| Метки: |
Нет меток, Требуется 1-ая метка записи!
|